183 related articles for article (PubMed ID: 14679674)
21. New Premier study suggest Preterax as a first-line antihypertensive.
Cardiovasc J S Afr; 2004; 15(1):40-1. PubMed ID: 15095752
[No Abstract] [Full Text] [Related]
22. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: a comparison with atenolol.
Asmar RG; London GM; O'Rourke ME; Safar ME;
Hypertension; 2001 Oct; 38(4):922-6. PubMed ID: 11641310
[TBL] [Abstract][Full Text] [Related]
23. [Clinical efficacy of noliprel in the treatment of hypertension. Main results of ETALON].
Oganov RG; Nebieridze DV
Kardiologiia; 2004; 44(3):66-9. PubMed ID: 15489830
[No Abstract] [Full Text] [Related]
24. Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice.
Mazza A; Lenti S; Schiavon L; Sacco AP; Dell'Avvocata F; Rigatelli G; Ramazzina E
Adv Ther; 2017 Apr; 34(4):975-985. PubMed ID: 28299716
[TBL] [Abstract][Full Text] [Related]
25. [Efficacy of a converting enzyme inhibitor in the prevention of recurrence of stroke].
Masson C
Presse Med; 2001 Nov; 30(35):1716-7. PubMed ID: 11775593
[No Abstract] [Full Text] [Related]
26. Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
Mourad JJ; Amodeo C; de Champvallins M; Brzozowska-Villatte R; Asmar R;
J Hypertens; 2017 Jul; 35(7):1481-1495. PubMed ID: 28306636
[TBL] [Abstract][Full Text] [Related]
27. ADVANCE: lessons from the run-in phase of a large study in type 2 diabetes.
Perkovic V; Joshi R; Patel A; Bompoint S; Chalmers J;
Blood Press; 2006; 15(6):340-6. PubMed ID: 17472024
[TBL] [Abstract][Full Text] [Related]
28. Blood pressure-lowering for secondary prevention of stroke: ACE inhibition is not the key.
Bath P
Stroke; 2003 May; 34(5):1334-5. PubMed ID: 12702833
[No Abstract] [Full Text] [Related]
29. [Changes of elastic properties of peripheral vessels and parameters of endothelial function at the background of the use of fixed combination of perindopril and indapamide in patients with hypertensive disease].
Martynov AI; Sharkova NE; Obukhov AA
Kardiologiia; 2008; 48(4):25-8. PubMed ID: 18447836
[No Abstract] [Full Text] [Related]
30. Comparison of the combination of enalapril and a very low dose of hydrochlorothiazide with atenolol in patients with mild-to-moderate hypertension. Scandinavian Study Group.
Os I; Hotnes T; Dollerup J; Mogensen CE
Am J Hypertens; 1997 Aug; 10(8):899-904. PubMed ID: 9270085
[TBL] [Abstract][Full Text] [Related]
31. [Antihypertensive therapy in diabetic patients. What do the new data mean for the practice?].
Holzgreve H
MMW Fortschr Med; 2007 Sep; 149(38):19. PubMed ID: 18018408
[No Abstract] [Full Text] [Related]
32. Blood pressure reduction and ACE inhibition in secondary stroke prevention: mechanism uncertain.
Davis SM; Donnan GA
Stroke; 2003 May; 34(5):1335-6. PubMed ID: 12702835
[No Abstract] [Full Text] [Related]
33. Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide SR.
Páll D; Szántó I; Szabó Z
Clin Drug Investig; 2014 Oct; 34(10):701-8. PubMed ID: 25212574
[TBL] [Abstract][Full Text] [Related]
34. [Clinical trial of the month. ADVANCE: improved survival and better vascular and renal outcomes with a fixed combination of perindopril and indapamide in patients with type 2 diabetes].
Scheen AJ; Krzesinski JM
Rev Med Liege; 2007 Oct; 62(10):639-43. PubMed ID: 18069576
[TBL] [Abstract][Full Text] [Related]
35. [Vascular impact of anti-hypertensive treatment and renal protection].
Mogensen CE
Curr Med Res Opin; 2005; 21 Suppl 5():S23-8. PubMed ID: 16197649
[TBL] [Abstract][Full Text] [Related]
36. [Cardioprotective effects of anti-hypertensive medications].
Asmar RG
Curr Med Res Opin; 2005; 21 Suppl 5():S17-21. PubMed ID: 16197648
[TBL] [Abstract][Full Text] [Related]
37. Application in the STRATHE trial of a score system to compare the efficacy and the tolerability of different therapeutic strategies in the management of hypertension.
Waeber B; Mourad JJ
Vasc Health Risk Manag; 2008; 4(1):249-52. PubMed ID: 18629368
[TBL] [Abstract][Full Text] [Related]
38. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: comparison with atenolol.
London GM; Asmar RG; O'Rourke MF; Safar ME;
J Am Coll Cardiol; 2004 Jan; 43(1):92-9. PubMed ID: 14715189
[TBL] [Abstract][Full Text] [Related]
39. Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine.
Mancia G; Asmar R; Amodeo C; Mourad JJ; Taddei S; Gamba MA; Chazova IE; Puig JG
J Hypertens; 2015 Feb; 33(2):401-11. PubMed ID: 25380149
[TBL] [Abstract][Full Text] [Related]
40. [ADVANCE study: objectives, design and current status].
Chalmers J
Drugs; 2003; 63 Spec No 1():39-44. PubMed ID: 12708881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
